Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Sarcoma, Myeloid × Leyk × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other hematologic neoplasm 1

Conditions

Sarcoma, Myeloid 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Leukemia, Myeloid, Acute 1

Interventions

Sorafenib 1 Mitoxantrone 1 Leyk 1 Etoposide 1 Daunorubicin 1 Cytarabine 1 Bortezomib 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01371981 2025-11-26

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting

1,645 enrolled 32 charts

Other hematologic neoplasmSarcoma

Leukemia, Myeloid, Acute, Sarcoma, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡